In vitro human leukocyte labeling with 64Cu: an intraindividual comparison with 111In-oxine and 18F-FDG
- 7 May 2009
- journal article
- research article
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 36 (5), 545-549
- https://doi.org/10.1016/j.nucmedbio.2009.03.001
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Labeled leukocyte imaging: current status and future directions.2009
- Imaging of infectious diseases using [18F] fluorodeoxyglucose PET.2008
- PET/CT in Musculoskeletal InfectionSeminars in Musculoskeletal Radiology, 2007
- PET with FDG-labeled Leukocytes versus Scintigraphy with111In-Oxine–labeled Leukocytes for Detection of InfectionRadiology, 2006
- FDG PET of Infection and InflammationRadioGraphics, 2005
- 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammationSeminars in Nuclear Medicine, 2002
- The use of 2-[18F]fluoro-2-deoxy-d-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomographyInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992
- Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study.Hypertension, 1991
- The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oximeNuclear Medicine Communications, 1988
- Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes.Radiology, 1988